• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

福氏耐格里虫感染存活:成功病例报告及新型治疗方法。

Surviving Naegleria fowleri infections: A successful case report and novel therapeutic approach.

机构信息

Bowling Green State University, School of Human Movement, Sport and Leisure Studies, Bowling Green, OH 43403, USA; School of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University, Townsville, Qld, Australia.

Institute of Occupational and Social Medicine, RWTH Aachen Technical University, Pauwelsstr. 30, D-52074 Aachen, Germany.

出版信息

Travel Med Infect Dis. 2017 Mar-Apr;16:49-51. doi: 10.1016/j.tmaid.2016.12.005. Epub 2016 Dec 22.

DOI:10.1016/j.tmaid.2016.12.005
PMID:28013053
Abstract

Naegleria fowleri is a deadly human pathogen recognized as the causative agent of Primary Amoebic Meningitis (PAM). N. fowleri is commonly found in warm freshwater environments such as natural or man-made lakes, hot springs, and resort spas frequented by tourists. PAM infections have a mortality rate between 95 and 99% with minimal progress being made toward a successful treatment therapy. We report the case of a 12-year old American female who survived a PAM infection and propose a new drug therapy which includes the antimicrobial drug Miltefosine.

摘要

福氏耐格里阿米巴是一种致命的人类病原体,被认为是原发性阿米巴脑膜脑炎(PAM)的病原体。福氏耐格里阿米巴常见于温暖的淡水环境中,如自然或人工湖泊、温泉和游客常去的度假胜地温泉。PAM 感染的死亡率在 95%到 99%之间,目前在成功的治疗方法方面进展甚微。我们报告了一例 12 岁美国女性 PAM 感染存活的病例,并提出了一种新的药物治疗方法,包括抗菌药物米替福新。

相似文献

1
Surviving Naegleria fowleri infections: A successful case report and novel therapeutic approach.福氏耐格里虫感染存活:成功病例报告及新型治疗方法。
Travel Med Infect Dis. 2017 Mar-Apr;16:49-51. doi: 10.1016/j.tmaid.2016.12.005. Epub 2016 Dec 22.
2
Naegleria fowleri That Induces Primary Amoebic Meningoencephalitis: Rapid Diagnosis and Rare Case of Survival in a 12-Year-Old Caucasian Girl.引发原发性阿米巴脑膜脑炎的福氏耐格里阿米巴:12岁白人女孩的快速诊断及罕见存活病例
Lab Med. 2016 May;47(2):149-54. doi: 10.1093/labmed/lmw008. Epub 2016 Mar 15.
3
Swimming with death: Naegleria fowleri infections in recreational waters.与死亡共泳:在娱乐水中感染福氏耐格里虫。
Travel Med Infect Dis. 2010 Jul;8(4):201-6. doi: 10.1016/j.tmaid.2010.06.001. Epub 2010 Jul 13.
4
Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case.新型治疗药物米替福新用于治疗原发性阿米巴脑膜脑炎:1例死亡病例和1例存活病例报告。
Clin Infect Dis. 2016 Mar 15;62(6):774-6. doi: 10.1093/cid/civ1021. Epub 2015 Dec 17.
5
Primary Amoebic Meningoencephalitis by : Pathogenesis and Treatments.原发性阿米巴脑膜脑炎:发病机制与治疗。
Biomolecules. 2021 Sep 6;11(9):1320. doi: 10.3390/biom11091320.
6
The therapeutic strategies against Naegleria fowleri.针对福氏耐格里阿米巴的治疗策略。
Exp Parasitol. 2018 Apr;187:1-11. doi: 10.1016/j.exppara.2018.02.010. Epub 2018 Mar 1.
7
Naegleria fowleri: Diagnosis, Pathophysiology of Brain Inflammation, and Antimicrobial Treatments.福氏耐格里阿米巴:诊断、脑炎症理生理学和抗菌治疗。
ACS Chem Neurosci. 2016 Sep 21;7(9):1178-9. doi: 10.1021/acschemneuro.6b00232. Epub 2016 Aug 15.
8
Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and Voriconazole.采用米替福新和伏立康唑新治疗方案成功治疗原发性阿米巴脑膜脑炎。
Acta Parasitol. 2022 Sep;67(3):1421-1424. doi: 10.1007/s11686-022-00591-9. Epub 2022 Jul 21.
9
Killer amoebas: Primary amoebic meningoencephalitis in a changing climate.致命变形虫:气候变化下的原发性阿米巴脑膜脑炎
JAAPA. 2019 Jun;32(6):30-35. doi: 10.1097/01.JAA.0000558238.99250.4a.
10
Torn from the Headlines: Surviving the "Brain Eating Amoeba".头条新闻:从“食脑变形虫”感染中存活
ACS Chem Neurosci. 2016 Oct 19;7(10):1313. doi: 10.1021/acschemneuro.6b00282.

引用本文的文献

1
Potential Inhibitors of Human- Interactions: An In Vitro Extracellular Matrix-Based Model.人类相互作用的潜在抑制剂:一种基于体外细胞外基质的模型。
Mar Drugs. 2025 Jul 30;23(8):306. doi: 10.3390/md23080306.
2
Infections: Bridging Clinical Observations and Epidemiological Insights.感染:连接临床观察与流行病学见解
J Clin Med. 2025 Jan 15;14(2):526. doi: 10.3390/jcm14020526.
3
Amoebas: the omnipotent organism and silent assassin.变形虫:全能的生物体与无声的杀手。
Mol Biol Rep. 2025 Jan 24;52(1):160. doi: 10.1007/s11033-025-10256-1.
4
Portrait of a Cerebral Killer.一个脑部杀手的画像。
Diagnostics (Basel). 2025 Jan 3;15(1):89. doi: 10.3390/diagnostics15010089.
5
Therapeutic glycan-specific antibody binding mediates protection during primary amoebic meningoencephalitis.治疗性糖特异性抗体结合在原发性阿米巴脑膜脑炎中发挥保护作用。
Infect Immun. 2024 Oct 15;92(10):e0018324. doi: 10.1128/iai.00183-24. Epub 2024 Sep 5.
6
Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment.硝羟喹重新用作原发性阿米巴脑膜脑炎的替代治疗药物。
Antibiotics (Basel). 2023 Aug 3;12(8):1280. doi: 10.3390/antibiotics12081280.
7
A primary amoebic meningoencephalitis case associated with swimming in seawater.与海水中游泳相关的原发性阿米巴脑膜脑炎病例。
Parasitol Res. 2023 Oct;122(10):2451-2452. doi: 10.1007/s00436-023-07934-z. Epub 2023 Aug 9.
8
Marine Meroterpenoids Isolated from Induce Programmed Cell Death in .从……中分离出的海洋杂萜类化合物诱导……中的程序性细胞死亡。
Pharmaceuticals (Basel). 2023 Jul 17;16(7):1010. doi: 10.3390/ph16071010.
9
Systematic Review of Brain-Eating Amoeba: A Decade Update.脑食阿米巴:十年更新的系统综述。
Int J Environ Res Public Health. 2023 Feb 9;20(4):3021. doi: 10.3390/ijerph20043021.
10
The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis.4-氨甲基苯氧基苯并硼唑 AN3057 作为原发性阿米巴脑膜脑炎的潜在治疗选择。
Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0150622. doi: 10.1128/aac.01506-22. Epub 2023 Jan 23.